{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:17:49Z","timestamp":1792801069297,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"the Zhejiang Provincial Natural Science Foundation of China","award":["LY15H190002"],"award-info":[{"award-number":["LY15H190002"]}],"id":[{"id":"https:\/\/ror.org\/04aqat463","id-type":"ROR","asserted-by":"crossref"}]},{"name":"the Science Foundations of Health Bureau of Zhejiang Province","award":["2013KYB116"],"award-info":[{"award-number":["2013KYB116"]}]},{"name":"the Science Foundations of Health Bureau of Zhejiang Province","award":["2014KYA252"],"award-info":[{"award-number":["2014KYA252"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12944-016-0256-x","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T08:40:35Z","timestamp":1461746435000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Association between alpha-fetoprotein and metabolic syndrome in a Chinese asymptomatic population: a cross-sectional study"],"prefix":"10.1186","volume":"15","author":[{"given":"Yimin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linmin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juanwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guofang","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,27]]},"reference":[{"issue":"5","key":"256_CR1","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/jdi.12313","volume":"6","author":"AR Hong","year":"2015","unstructured":"Hong AR, Lim S. Clinical characteristics of metabolic syndrome in Korea, and its comparison with other Asian countries. J Diab Investig. 2015;6(5):508\u201315.","journal-title":"J Diab Investig"},{"key":"256_CR2","first-page":"11","volume":"435","author":"L Mayans","year":"2015","unstructured":"Mayans L. Metabolic Syndrome: Insulin Resistance and Prediabetes. FP Essent. 2015;435:11\u20136.","journal-title":"FP Essent"},{"key":"256_CR3","first-page":"17","volume":"435","author":"DA Bragg","year":"2015","unstructured":"Bragg DA, Walling A. Metabolic Syndrome: Hyperlipidemia. FP Essent. 2015;435:17\u201323.","journal-title":"FP Essent"},{"issue":"10","key":"256_CR4","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1016\/j.metabol.2015.06.019","volume":"64","author":"HT Tie","year":"2015","unstructured":"Tie HT, Shi R, Li ZH, Zhang M, Zhang C, Wu QC. Risk of major adverse cardiovascular events in patients with metabolic syndrome after revascularization: A meta-analysis of eighteen cohorts with 18457 patients. Metabolism. 2015;64(10):1224\u201334.","journal-title":"Metabolism"},{"key":"256_CR5","first-page":"24","volume":"435","author":"T Williams","year":"2015","unstructured":"Williams T. Metabolic Syndrome. Nonalcoholic Fatty Liver Dis FP Essent. 2015;435:24\u20139.","journal-title":"Nonalcoholic Fatty Liver Dis FP Essent"},{"key":"256_CR6","doi-asserted-by":"crossref","unstructured":"Gu D, Reynolds K, Wu X, Chen J, Duan X, Reynolds RF, Whelton PK, He J, InterASIA Collaborative Group. InterASIA Collaborative Group. Prevalence of the metabolic syndrome and overweight among adults in China. Lancet. 2005;365(9468):1398\u2013405.","DOI":"10.1016\/S0140-6736(05)66375-1"},{"key":"256_CR7","unstructured":"Zhou HC, Lai YX, Shan ZY, Jia WP, Yang WY, Lu JM, Weng JP, Ji LN, Liu J, Tian HM, Ji QH, Zhu da L, Chen L, Guo XH, Zhao ZG, Li Q, Zhou ZG, Ge JP, Shan GL. Effectiveness of different waist circumference cut-off values in predicting metabolic syndrome prevalence and risk factors in adults in China. Biomed Environ Sci. 2014;27(5):325\u201334."},{"issue":"15","key":"256_CR8","first-page":"00222","volume":"S1931\u20135244","author":"FK Welty","year":"2015","unstructured":"Welty FK, Alfaddagh A, Elajami TK. Targeting inflammation in metabolic syndrome. Transl Res. 2015;S1931\u20135244(15):00222\u20134.","journal-title":"Transl Res"},{"issue":"8","key":"256_CR9","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s005350200111","volume":"37","author":"Y Takikawa","year":"2002","unstructured":"Takikawa Y, Suzuki K. Is AFP a new reliable marker of liver regeneration in acute hepatic failure? J Gastroenterol. 2002;37(8):681\u20132.","journal-title":"J Gastroenterol"},{"issue":"2","key":"256_CR10","first-page":"84","volume":"8","author":"S Yachnin","year":"1978","unstructured":"Yachnin S. The clinical significance of human alpha-fetoprotein. Ann Clin Lab Sci. 1978;8(2):84\u201390.","journal-title":"Ann Clin Lab Sci"},{"issue":"2","key":"256_CR11","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/10408368109105870","volume":"15","author":"BF Crandall","year":"1981","unstructured":"Crandall BF. Alpha-fetoprotein: a review. Crit Rev Clin Lab Sci. 1981;15(2):127\u201385.","journal-title":"Crit Rev Clin Lab Sci"},{"key":"256_CR12","doi-asserted-by":"crossref","unstructured":"Babal\u0131 A, Cakal E, Purnak T, B\u0131y\u0131ko\u011flu I, Cakal B, Y\u00fcksel O, K\u00f6kl\u00fc S.. Serum \u03b1-fetoprotein levels in liver steatosis. Hepatol Int. 2009;3(4):551\u20135.","DOI":"10.1007\/s12072-009-9156-8"},{"issue":"2","key":"256_CR13","first-page":"98","volume":"20","author":"JT Wu","year":"1990","unstructured":"Wu JT. Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review. Ann Clin Lab Sci. 1990;20(2):98\u2013105.","journal-title":"Ann Clin Lab Sci"},{"issue":"9","key":"256_CR14","first-page":"497","volume":"130","author":"LX Qin","year":"2004","unstructured":"Qin LX, Tang ZY. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. J Cancer Res Clin Oncol. 2004;130(9):497\u2013513.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"2","key":"256_CR15","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cld.2015.01.005","volume":"19","author":"RJ Wong","year":"2015","unstructured":"Wong RJ, Ahmed A, Gish RG. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders. Clin Liver Dis. 2015;19(2):309\u201323.","journal-title":"Clin Liver Dis"},{"key":"256_CR16","doi-asserted-by":"crossref","unstructured":"Xu P, Xu CF, Wan XY, Yu CH, Shen C, Chen P, Xu GY, Li YM. Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study. World J Gastroenterol. 2014;20(33):11865\u201370.","DOI":"10.3748\/wjg.v20.i33.11865"},{"issue":"11","key":"256_CR17","first-page":"801","volume":"17","author":"JH Shao","year":"2009","unstructured":"Shao JH, Jin YL, Yu LL, Shen X, Li DX, Wang K. study on the application and evaluation of different diagnostic criteria for metabolic syndrome in community people. Chin J Diab. 2009;17(11):801\u20133.","journal-title":"Chin J Diab"},{"key":"256_CR18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/1475-2840-10-100","volume":"10","author":"SN Verhagen","year":"2011","unstructured":"Verhagen SN, Wassink AM, van der Graaf Y, Gorter PM, Visseren FL. SMART Study Group. Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study. Cardiovasc Diabetol. 2011;10:100.","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"256_CR19","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/msj.20212","volume":"77","author":"EJ Gallagher","year":"2010","unstructured":"Gallagher EJ, Leroith D, Karnieli E. Insulin resistance in obesity as the underlying cause for the metabolic syndrome. Mt Sinai J Med. 2010;77(5):511\u201323.","journal-title":"Mt Sinai J Med"},{"issue":"Suppl 1","key":"256_CR20","doi-asserted-by":"crossref","first-page":"S160","DOI":"10.2337\/diabetes.50.2007.S160","volume":"50","author":"D Porte Jr","year":"2001","unstructured":"Porte Jr D, Kahn SE. Beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes. 2001;50 Suppl 1:S160\u2013163.","journal-title":"Diabetes"},{"issue":"4","key":"256_CR21","doi-asserted-by":"crossref","first-page":"E906","DOI":"10.1152\/ajpendo.00117.2003","volume":"285","author":"DE Kelley","year":"2003","unstructured":"Kelley DE, McKolanis TM, Hegazi RA, Kuller LH, Kalhan SC. Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab. 2003;285(4):E906\u201316.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"1","key":"256_CR22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/ATVBAHA.107.147538","volume":"28","author":"A Kotronen","year":"2008","unstructured":"Kotronen A, Yki-Jarvinen H. Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2008;28(1):27\u201338.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"6","key":"256_CR23","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.3390\/nu7064995","volume":"7","author":"E Fabbrini","year":"2015","unstructured":"Fabbrini E, Magkos F. Hepatic Steatosis as a Marker of Metabolic Dysfunction. Nutrients. 2015;7(6):4995\u20135019.","journal-title":"Nutrients"},{"issue":"11","key":"256_CR24","doi-asserted-by":"crossref","first-page":"E526","DOI":"10.1503\/cmaj.092144","volume":"182","author":"L Porepa","year":"2010","unstructured":"Porepa L, Ray JG, Sanchez-Romeu P, Booth GL. Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. CMAJ. 2010;182(11):E526\u2013531.","journal-title":"CMAJ"},{"issue":"3","key":"256_CR25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.2040-1124.2011.00111.x","volume":"2","author":"T Matsuzaka","year":"2011","unstructured":"Matsuzaka T, Shimano H. Molecular mechanisms involved in hepatic steatosis and insulin resistance. J Diab Investig. 2011;2(3):170\u20135.","journal-title":"J Diab Investig"},{"issue":"4","key":"256_CR26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/ijo.2015.13","volume":"39","author":"M Desai","year":"2015","unstructured":"Desai M, Jellyman JK, Ross MG. Epigenomics, gestational programming and risk of metabolic syndrome. Int J Obes (Lond). 2015;39(4):633\u201341.","journal-title":"Int J Obes (Lond)"},{"key":"256_CR27","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.lfs.2016.02.002","volume":"148","author":"V Rani","year":"2016","unstructured":"Rani V, Deep G, Singh RK, Palle K, Yadav UC. Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies. Life Sci. 2016;148:183\u201393.","journal-title":"Life Sci"},{"key":"256_CR28","doi-asserted-by":"crossref","unstructured":"Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752\u201361.","DOI":"10.1172\/JCI21625"},{"issue":"2","key":"256_CR29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.14336\/AD.2014.0305","volume":"6","author":"F Bonomini","year":"2015","unstructured":"Bonomini F, Rodella LF, Rezzani R. Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis. 2015;6(2):109\u201320.","journal-title":"Aging Dis"},{"issue":"1","key":"256_CR30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bpg.2004.10.003","volume":"19","author":"MF Yuen","year":"2005","unstructured":"Yuen MF, Lai CL. Serological markers of liver cancer. Best Pract Res Clin Gastroenterol. 2005;19(1):91\u20139.","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"256_CR31","unstructured":"Baig JA, Alam JM, Mahmood SR, Baig M, Shaheen R, Sultana I, Waheed A. Hepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP). J Ayub Med Coll Abbottabad. 2009;21(1):72\u20135."},{"key":"256_CR32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.1975.03260010040018","volume":"233","author":"JR Bloomer","year":"1975","unstructured":"Bloomer JR, Waldmann TA, McIntire KR, Klatskin G. alpha-fetoprotein in noneoplastic hepatic disorders. JAMA. 1975;233:38\u201341.","journal-title":"JAMA"},{"issue":"1 Suppl","key":"256_CR33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0168-8278(00)80412-2","volume":"32","author":"N Fausto","year":"2000","unstructured":"Fausto N. Liver regeneration. J Hepatol. 2000;32(1 Suppl):19\u201331.","journal-title":"J Hepatol"},{"issue":"5","key":"256_CR34","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1365-2613.2006.00485.x","volume":"87","author":"WD Kuhlmann","year":"2006","unstructured":"Kuhlmann WD, Peschke P. Hepatic progenitor cells, stem cells, and AFP expression in models of liver injury. Int J Exp Pathol. 2006;87(5):343\u201359.","journal-title":"Int J Exp Pathol"},{"issue":"24","key":"256_CR35","first-page":"5825","volume":"58","author":"MD Dabeva","year":"1998","unstructured":"Dabeva MD, Laconi E, Oren R, Petkov PM, Hurston E, Shafritz DA. Liver regeneration and alpha-fetoprotein messenger RNA expression in the retrorsine model for hepatocyte transplantation. Cancer Res. 1998;58(24):5825\u201334.","journal-title":"Cancer Res"},{"issue":"11 Pt. 2","key":"256_CR36","first-page":"4239","volume":"36","author":"S Sell","year":"1976","unstructured":"Sell S, Becker FF, Leffert HL, Watabe L. Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and adult oncogenesis. Cancer Res. 1976;36(11 Pt. 2):4239\u201349.","journal-title":"Cancer Res"},{"issue":"1","key":"256_CR37","first-page":"4","volume":"56","author":"E Farber","year":"1987","unstructured":"Farber E, Sarma DS. Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest. 1987;56(1):4\u201322.","journal-title":"Lab Invest"},{"key":"256_CR38","doi-asserted-by":"crossref","unstructured":"Nishida N, Yada N, Hagiwara S, Sakurai T, Kitano M, Kudo M. Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 2016; doi: 10.1111\/jgh.13318.","DOI":"10.1111\/jgh.13318"},{"issue":"6","key":"256_CR39","doi-asserted-by":"crossref","first-page":"146","DOI":"10.4291\/wjgp.v2.i6.146","volume":"2","author":"SF Assimakopoulos","year":"2011","unstructured":"Assimakopoulos SF, Tsamandas AC, Alexandris IH, Georgiou C, Vagianos CE, Scopa CD. Stimulation of oval cell and hepatocyte proliferation by exogenous bombesin and neurotensin in partially hepatectomized rats. World J Gastrointest Pathophysiol. 2011;2(6):146\u201354.","journal-title":"World J Gastrointest Pathophysiol"},{"issue":"7","key":"256_CR40","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1365-2184.1996.tb00982.x","volume":"29","author":"MR Alison","year":"1996","unstructured":"Alison MR, Golding MH, Sarraf CE. Pluripotential liver stem cells: facultative stem cells located in the biliary tree. Cell Prolif. 1996;29(7):373\u2013402.","journal-title":"Cell Prolif"},{"key":"256_CR41","doi-asserted-by":"crossref","unstructured":"Hu KQ, Currie SL, Shen H, Cheung RC, Ho SB, Bini EJ, McCracken JD, Morgan T, Br\u00e4u N, Schmidt WN, et al. VA HCV-001 Study Group: Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans. Dig Dis Sci. 2007;52(2):570\u20138.","DOI":"10.1007\/s10620-006-9418-4"},{"key":"256_CR42","doi-asserted-by":"crossref","unstructured":"Goldstein NS, Blue DE, Hankin R, Hunter S, Bayati N, Silverman AL, Gordon SC. Serum alpha-fetoprotein levels in patients with chronic hepatitis C. Relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores. Am J Clin Pathol. 1999;111(6):811\u20136.","DOI":"10.1093\/ajcp\/111.6.811"},{"issue":"3","key":"256_CR43","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1079\/PNS2005445","volume":"64","author":"HM Roche","year":"2005","unstructured":"Roche HM, Phillips C, Gibney MJ. The metabolic syndrome: the crossroads of diet and genetics. Proc Nutr Soc. 2005;64(3):371\u20137.","journal-title":"Proc Nutr Soc"},{"issue":"1","key":"256_CR44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/mnfr.201100531","volume":"56","author":"P Perez-Martinez","year":"2012","unstructured":"Perez-Martinez P, Garcia-Rios A, Delgado-Lista J, Perez-Jimenez F, Lopez-Miranda J. Metabolic syndrome: evidences for a personalized nutrition. Mol Nutr Food Res. 2012;56(1):67\u201376.","journal-title":"Mol Nutr Food Res"},{"key":"256_CR45","doi-asserted-by":"crossref","unstructured":"Iyer A, Kauter K, Alam MA, Hwang SH, Morisseau C, Hammock BD, Brown L. Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats. Exp Diabetes Res. 2012;2012:758614.","DOI":"10.1155\/2012\/758614"},{"key":"256_CR46","doi-asserted-by":"crossref","unstructured":"Panchal SK, Poudyal H, Iyer A, Nazer R, Alam MA, Diwan V, Kauter K, Sernia C, Campbell F, Ward L, Gobe G, Fenning A, Brown L. High-carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol. 2011;57(5):611\u201324.","DOI":"10.1097\/FJC.0b013e3181feb90a"},{"issue":"3","key":"256_CR47","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/j.gastro.2014.06.043","volume":"147","author":"F Marra","year":"2014","unstructured":"Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology. 2014;147(3):577\u201394.","journal-title":"Gastroenterology"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-016-0256-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T07:53:10Z","timestamp":1498290790000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-016-0256-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,27]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["256"],"URL":"https:\/\/doi.org\/10.1186\/s12944-016-0256-x","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,27]]},"article-number":"85"}}